Unraveling the unphosphorylated STAT3-unphosphorylated NF-κB pathway in loss of function STAT3 Hyper IgE syndrome.

Autor: Karim A; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Garg R; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Saikia B; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Tiwari A; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Sahu S; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Malhotra M; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Minz RW; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Rawat A; Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Singh S; Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Suri D; Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Aug 20; Vol. 15, pp. 1332817. Date of Electronic Publication: 2024 Aug 20 (Print Publication: 2024).

Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophils.

Autor: Rubey KM; https://ror.org/01z7r7q48 Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA rubeyk@chop.edu., Freeman A; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Mukhitov AR; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Paris AJ; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lin SM; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rue R; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fazelinia H; https://ror.org/01z7r7q48 The Proteomics Core Facility, The Children's Hospital of Philadelphia, Research Institute, Philadelphia, PA, USA., Spruce LA; https://ror.org/01z7r7q48 The Proteomics Core Facility, The Children's Hospital of Philadelphia, Research Institute, Philadelphia, PA, USA., Roof J; https://ror.org/01z7r7q48 The Proteomics Core Facility, The Children's Hospital of Philadelphia, Research Institute, Philadelphia, PA, USA., Brenner JS; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pharmacology, University of Pennsylvania, Philadelphia, PA, USA., Heimall J; https://ror.org/01z7r7q48 Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Krymskaya VP; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Life science alliance [Life Sci Alliance] 2024 Aug 12; Vol. 7 (11). Date of Electronic Publication: 2024 Aug 12 (Print Publication: 2024).

A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.

Autor: Mohammadi T; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Azizi G; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Rafiemanesh H; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Farahani P; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Nirouei M; Alborz University of Medical Sciences, Karaj, Iran., Tavakol M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. marziyeh.tavakol@gmail.com.; Department of Pediatrics, Alborz University of Medical Sciences, Karaj, Iran. marziyeh.tavakol@gmail.com.

Publikováno v: Clinical and experimental medicine [Clin Exp Med] 2023 Dec; Vol. 23 (8), pp. 4835-4859. Date of Electronic Publication: 2023 Nov 04.

Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India.

Autor: Kumar Jindal A; Allergy Immunology Unit., Sil A; Allergy Immunology Unit., Aggarwal R; Allergy Immunology Unit., Tyagi R; Allergy Immunology Unit., Mondal S; Allergy Immunology Unit., Singh A; Allergy Immunology Unit., Barman P; Allergy Immunology Unit., Chawla S; Allergy Immunology Unit., Loganathan SK; Allergy Immunology Unit., Gupta K; Department of Histopathology., Vinay K; Department of Dermatology, Venerology and Leprology., Mahajan R; Department of Dermatology, Venerology and Leprology., Saikia B; Department of Immunopathology., Kaur G; Allergy Immunology Unit., Sharma R; Department of Paediatrics., Saka R; Allergy Immunology Unit., Bhatia A; Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Sankhyan N; Paediatric Neurology Unit, Department of Paediatrics, Advanced Paediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Pandiarajan V; Allergy Immunology Unit., Pilania R; Allergy Immunology Unit., Dhaliwal M; Allergy Immunology Unit., Sharma S; Allergy Immunology Unit., Vyas S; Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Suri D; Allergy Immunology Unit., Rawat A; Allergy Immunology Unit., Singh S; Allergy Immunology Unit.

Publikováno v: Clinical and experimental dermatology [Clin Exp Dermatol] 2024 Feb 14; Vol. 49 (3), pp. 226-234.

Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency.

Autor: Liquidano-Perez E; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico., Maza-Ramos G; Private Practice, 'SkinAllergy', Acapulco, Guerrero, Mexico., Perez Arias BA; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico., Lugo Reyes SO; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico., Barragan Arevalo T; Department of Genetics, Institute of Ophthalmology 'Conde de Valenciana', Mexico City, Mexico., Solorzano-Morales SA; Radiology Department, National Institute of Pediatrics, Mexico City, Mexico., Venegas Montoya E; Highly Specialized Medical Unit 25, Mexican Social Security Institute, Torreón, Mexico., Staines-Boone AT; Highly Specialized Medical Unit 25, Mexican Social Security Institute, Torreón, Mexico., Guzmán Cotaya R; Private Practice, 'Chavitos Clinic', Merida, Yucatan, Mexico., Okada S; Hiroshima University, Hiroshima, Japan., Picard C; Hopital Necker Enfants Malades, Paris, France., Patin E; Institut Pasteur, Paris, France., Ramirez-Uribe N; Hematopoietic Stem Cell Transplantation Unit, National Institute of Pediatrics, Mexico City, Mexico., Bustamante-Ogando JC; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico., Scheffler-Mendoza SC; Immunology Service, National Institute of Pediatrics, Mexico City, Mexico., Yamazaki-Nakashimada MA; Immunology Service, National Institute of Pediatrics, Mexico City, Mexico., Saez-de-Ocariz M; Dermatology Service, National Institute of Pediatrics, Mexico City, Mexico., Espinosa Padilla SE; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico., Gonzalez-Serrano ME; Primary Immunodeficiency Laboratory, National Institute of Pediatrics, Mexico City, Mexico.

Publikováno v: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2024 Feb; Vol. 35 (2), pp. e14073.